Europe begins 210-day review of Telix brain cancer imaging candidate

The filing covers key European markets and seeks a broad glioma imaging label for adults and children. If Day 210 is positive, national authorizations follow.Read More

What's Trending

Luxury travel bookings rose 59% as sales climbed 69%

U.S. Global Investors Declares Continued Monthly Dividend, Highlights Strength in Travel Spending

U.S. Global Investors Declares Continued Monthly Dividend, Highlights Strength in Travel Spending

Sullivan & Cromwell Raids Kirkland’s Private Equity Team

Portnoy Law Firm Announces Class Action on Behalf of PROCEPT BioRobotics Corporation Investors

NJDOL Posts the Names of Eight Businesses with Outstanding Wage, Benefit and Tax Law Violations to its Workplace Accountability in Labor List (The WALL)

CT court upholds law: No religious exemptions to vaccines

Plaintiffs Change Approach After Collective Actions Fail in FedEx Overtime Dispute

Europe begins 210-day review of Telix brain cancer imaging candidate

Luxury travel bookings rose 59% as sales climbed 69%

U.S. Global Investors Declares Continued Monthly Dividend, Highlights Strength in Travel Spending

U.S. Global Investors Declares Continued Monthly Dividend, Highlights Strength in Travel Spending

Insider locks in $2.50 warrants at XCF Global (SAFX)

Leave A Reply Cancel Reply

What's Trending

Europe begins 210-day review of Telix brain cancer imaging candidate

Related Posts

Leave A Reply Cancel Reply

Subscribe to MGSN